Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2025)

Autolus Therapeutics (AUTL) has disclosed Other Operating Expenses for 6 consecutive years, with -$3000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Other Operating Expenses changed N/A year-over-year to -$3000.0, compared with a TTM value of -$3000.0 through Sep 2025, up 98.65%, and an annual FY2024 reading of -$223000.0, up 94.12% over the prior year.
  • Other Operating Expenses was -$3000.0 for Q1 2025 at Autolus Therapeutics, up from -$223000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$3000.0 in Q1 2025 and bottomed at -$3.8 million in Q1 2023.
  • Average Other Operating Expenses over 4 years is -$906400.0, with a median of -$223000.0 recorded in 2024.